Octagon Capital Advisors LP
CIK: 0001839435SEC EDGAR →
Portfolio Value
$823.7M
Holdings
27
As of
Q4 2025
New Positions
4
Closed Positions
8
Top 10 Holdings
| Rank | Stock | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | ABIVAX SA | 756,000 | $102.0M | 12.38% |
| 2 | DIANTHUS THERAPEUTICS INC | 2,416,667 | $99.6M | 12.09% |
| 3 | COGENT BIOSCIENCES INC | 2,350,000 | $83.5M | 10.13% |
| 4 | TAYSHA GENE THERAPIES INC | 8,859,911 | $48.7M | 5.92% |
| 5 | GOSSAMER BIO INC | 13,915,371 | $43.1M | 5.24% |
| 6 | KYMERA THERAPEUTICS INC | 535,000 | $41.6M | 5.05% |
| 7 | ARRIVENT BIOPHARMA INC | 1,971,054 | $39.7M | 4.81% |
| 8 | TREVI THERAPEUTICS INC | 2,815,000 | $35.2M | 4.28% |
| 9 | OCULAR THERAPEUTIX INC | 2,623,600 | $31.9M | 3.87% |
| 10 | MIND MEDICINE MINDMED INC | 2,230,000 | $29.9M | 3.63% |
Quarterly Changes
New Positions (9)
Sector Breakdown
| Sector | # Holdings | Value | % |
|---|---|---|---|
| Healthcare | 25 | $771.7M | 93.7% |
| Unknown | 2 | $51.9M | 6.3% |